Document is current
Any future updates will be listed below
-
Authors
Zhong, Mingxin https://orcid.org/0009-0008-8124-5689
Wang, Qian
Tian, Hui
Zhang, Bainian
Xu, Zhuo
Zhang, Yuanyuan
Tan, Chengjia
Hu, Xin
Wang, Tao
Feng, Daren
Xi, Zhenpeng
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (81202933, 81202933, 81202933, 81202933, 81202933, 81202933, 81202933, 81202933)
the Natural Science Foundation of Sichuan Province (2022NSFSC0592, 2022NSFSC0592, 2022NSFSC0592, 2022NSFSC0592, 2022NSFSC0592, 2022NSFSC0592, 2022NSFSC0592, 2022NSFSC0592)
the Science and Technology Plan Project of Mianyang City (2018YFZJ025, 2018YFZJ025, 2018YFZJ025, 2018YFZJ025, 2018YFZJ025, 2018YFZJ025, 2018YFZJ025, 2018YFZJ025)
- License Information
-
More Information
Article History
Received: 21 September 2024
Accepted: 4 December 2024
First Online: 19 December 2024
Declarations
:
: This study complied with ethical standards and is not applicable to human and/or animal studies. The sampling of plant materials conducted in this study has received approval from the landowner or governing body. Specifically, the collected <i>Magnolia</i> bark from Beichuan County originated from the medicinal material planting base in Wahugou Village and was approved by the owner of the base. The <i>Magnolia</i> bark from Baoxing County was gathered from a private <i>Magnolia</i> plantation in the Grand Canyon of Dongla Mountain with the consent of the landowner. The collected <i>Magnolia</i> bark from Nanjiang County comes from the Micangshan National Forest Park (a non-protected forest area) and has been approved by the head of the local forest farm. The collected <i>Magnolia</i> bark from Xuanhan County was derived from the planting base of Longsen Pharmaceutical and was approved by the head of Longsen Pharmaceutical.
: Not applicable.
: The authors declare no competing interests.
